Jump Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

Jump Financial’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-497,365	Closed	-$10.7M	–	2120
2026 Q1	$10.7M	Sell	497,365 -169,755	-25%	-$2.39M	0.14%	161
2025 Q4	$6.22M	Buy	667,120 +394,573	+145%	+$3.3M	0.08%	314
2025 Q3	$1.92M	Buy	+272,547	New	+$1.88M	0.02%	752
2024 Q4	–	Sell	-38,010	Closed	-$529K	–	1727
2024 Q3	$529K	Buy	+38,010	New	+$542K	0.01%	1080
2024 Q2	–	Sell	-32,142	Closed	-$531K	–	1892
2024 Q1	$531K	Buy	+32,142	New	+$481K	0.01%	1150
2023 Q3	–	Sell	-70,031	Closed	-$836K	–	1926
2023 Q2	$836K	Sell	70,031 -30,357	-30%	-$396K	0.03%	777
2023 Q1	$1.34M	Buy	100,388 +84,024	+513%	+$1.64M	0.05%	489
2022 Q4	$352K	Buy	+16,364	New	+$336K	0.02%	951

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jump Financial's DAWN Position: Q2 2026 in Review

Jump Financial sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 497,365 shares — an estimated $10.7M sold.

Jump Financial first reported a position in DAWN in Q4 2022 and held it in 8 quarters. The position peaked at $10.7M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Jump Financial reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jump Financial sold 497,365 Day One Biopharmaceuticals shares in Q2 2026, an estimated $10.7M.
Jump Financial first reported a position in Day One Biopharmaceuticals in Q4 2022 and held it in 8 quarters.
Jump Financial's Day One Biopharmaceuticals position peaked at $10.7M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.